IBG-Biobanking and Biomolecular Resources Platform (IBG-BIOBANK), Turkey

Registration Status: Pending

Objective: With a governance model in line with the ISO 20387-2018 “Biotechnology – Biobanking – Biobanking requirements” standards, as well as an infrastructure enabling good quality and standardized access to biological material, IBG-Biobanking and Biomolecular Resources Platform (IBG-BIOBANK)* is a “research biobank” established to provide support for researchers and clinicians for the advancement of basic and technological research in the healthcare field. Through enabling the preservation of biological samples and related data in high quality, easily accessible and sustainable conditions; IBG-BIOBANK aims primarily to contribute to a healthier living for the public, the prevention of diseases, the discovery of early diagnosis biomarkers and kits. IBG-BIOBANK was set up with the priority of supporting research on “rare diseases” and “cancer”, aims to contribute to the prevention, diagnosis and treatment of these diseases, as well as improving the quality of life, and continues its activities under the following four headings: (1) To create, preserve and share sample /data collections through research collaborations, (2) To conduct R&D activities in order to contribute to the development disease models (such as cell lines and tumor models) and innovative biobanking techniques for their collection and storage, (3) To provide support in drawing up quality standards and regulations on Ethical, Legal and Social Implications (ELSI), as well as implementing and maintaining these, (4) To conduct activities on raising awareness on research biobanks.

Registered Biobank Name	IBG-Biobanking and Biomolecular Resources Platform (IBG-BIOBANK)
Biobank Leader	Sanem Tercan Avcı
Country	Turkey
Email for biobank inquiries	sanem.avci@ibg.edu.tr
Principal Investigator	Neşe Atabey
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).